148 related articles for article (PubMed ID: 33306758)
41. Pre-treatment metabolic tumour volume and total lesion glycolysis are superior to conventional positron-emission tomography/computed tomography variables for outcome prediction in patients with newly diagnosed multiple myeloma in clinical practice.
Terao T; Machida Y; Tsushima T; Miura D; Narita K; Kitadate A; Takeuchi M; Matsue K
Br J Haematol; 2020 Oct; 191(2):223-230. PubMed ID: 32253760
[TBL] [Abstract][Full Text] [Related]
42. Functional imaging early during (chemo)radiotherapy for response prediction in head and neck squamous cell carcinoma; a systematic review.
Martens RM; Noij DP; Ali M; Koopman T; Marcus JT; Vergeer MR; de Vet H; de Jong MC; Leemans CR; Hoekstra OS; de Bree R; de Graaf P; Boellaard R; Castelijns JA
Oral Oncol; 2019 Jan; 88():75-83. PubMed ID: 30616800
[TBL] [Abstract][Full Text] [Related]
43. Predictive markers, including total lesion glycolysis, for the response of lymph node(s) metastasis from head and neck squamous cell carcinoma treated by chemoradiotherapy.
Nishimura G; Komatsu M; Hata M; Yabuki K; Taguchi T; Takahashi M; Shiono O; Sano D; Arai Y; Takahashi H; Chiba Y; Oridate N
Int J Clin Oncol; 2016 Apr; 21(2):224-230. PubMed ID: 26272533
[TBL] [Abstract][Full Text] [Related]
44. Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis.
Pak K; Kim BS; Kim K; Kim IJ; Jun S; Jeong YJ; Shim HK; Kim SD; Cho KS
Am J Otolaryngol; 2018; 39(1):1-5. PubMed ID: 29056243
[TBL] [Abstract][Full Text] [Related]
45. Detecting interval metastases and response assessment using 18F-FDG PET/CT after neoadjuvant chemoradiotherapy for esophageal cancer.
Stiekema J; Vermeulen D; Vegt E; Voncken FE; Aleman BM; Sanders J; Boot H; van Sandick JW
Clin Nucl Med; 2014 Oct; 39(10):862-7. PubMed ID: 25140549
[TBL] [Abstract][Full Text] [Related]
46. Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas.
Roh JL; Kim JS; Kang BC; Cho KJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2014 Dec; 110(7):869-75. PubMed ID: 25088392
[TBL] [Abstract][Full Text] [Related]
47. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study.
Li QW; Zheng RL; Ling YH; Wang QX; Xiao WW; Zeng ZF; Fan W; Li LR; Gao YH
Abdom Radiol (NY); 2016 Aug; 41(8):1448-55. PubMed ID: 27116012
[TBL] [Abstract][Full Text] [Related]
48. Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.
Abd El-Hafez YG; Moustafa HM; Khalil HF; Liao CT; Yen TC
Oral Oncol; 2013 Mar; 49(3):261-8. PubMed ID: 23036774
[TBL] [Abstract][Full Text] [Related]
49. Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.
Satoh Y; Onishi H; Nambu A; Araki T
Radiology; 2014 Jan; 270(1):275-81. PubMed ID: 24029640
[TBL] [Abstract][Full Text] [Related]
50. Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in Burkitt lymphoma.
Albano D; Bosio G; Pagani C; Re A; Tucci A; Giubbini R; Bertagna F
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):87-96. PubMed ID: 30276438
[TBL] [Abstract][Full Text] [Related]
51. Impact of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography on Therapeutic Decisions and Radiotherapy Planning in Head and Neck Squamous Carcinoma: A Retrospective Study of 46 Patients.
Pham A; Garai I; Árpád K; Dér Á; Szanto E; Hascsi Z; Bátyi F; Berényi E; Pham TM
Med Sci Monit; 2024 Jan; 30():e942122. PubMed ID: 38243589
[TBL] [Abstract][Full Text] [Related]
52. The role of sequential 18(F) -FDG PET/CT in predicting tumour response after preoperative chemoradiation for rectal cancer.
Sun W; Xu J; Hu W; Zhang Z; Shen W
Colorectal Dis; 2013 May; 15(5):e231-8. PubMed ID: 23384167
[TBL] [Abstract][Full Text] [Related]
53. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
Ding CY; Guo Z; Sun J; Yang WP; Li TR
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
[No Abstract] [Full Text] [Related]
54. Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: value of FDG volumetric imaging parameters.
Yu J; Cooley T; Truong MT; Mercier G; Subramaniam RM
J Med Imaging Radiat Oncol; 2014 Feb; 58(1):18-24. PubMed ID: 24529051
[TBL] [Abstract][Full Text] [Related]
55. Prognostic Value of the Volumetric Parameters of Dual-Time-Point
Okazaki E; Seura H; Hasegawa Y; Okamura T; Fukuda H
AJR Am J Roentgenol; 2019 Dec; 213(6):1366-1373. PubMed ID: 31509426
[No Abstract] [Full Text] [Related]
56. Mid-treatment Fluorodeoxyglucose Positron Emission Tomography in Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma Treated with Primary Radiotherapy: Nodal Metabolic Response Rate can Predict Treatment Outcomes.
Lin P; Min M; Lai K; Lee M; Holloway L; Xuan W; Bray V; Fowler A; Lee CS; Yong J
Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):e586-e598. PubMed ID: 34373179
[TBL] [Abstract][Full Text] [Related]
57. Clinical impact of
Jung JH; Lee SW; Son SH; Kim CY; Lee CH; Jeong JH; Jeong SY; Ahn BC; Lee J
Head Neck; 2017 Mar; 39(3):447-455. PubMed ID: 27726225
[TBL] [Abstract][Full Text] [Related]
58. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
59. Changes in serial multiparametric MRI and FDG-PET/CT functional imaging during radiation therapy can predict treatment response in patients with head and neck cancer.
Trada Y; Keall P; Jameson M; Moses D; Lin P; Chlap P; Holloway L; Min M; Forstner D; Fowler A; Lee MT
Eur Radiol; 2023 Dec; 33(12):8788-8799. PubMed ID: 37405500
[TBL] [Abstract][Full Text] [Related]
60. Usefulness of FDG PET/CT derived parameters in prediction of histopathological finding during the surgery in patients with pancreatic adenocarcinoma.
Myssayev A; Myssayev A; Ideguchi R; Eguchi S; Adachi T; Sumida Y; Tobinaga S; Uetani M; Kudo T
PLoS One; 2019; 14(1):e0210178. PubMed ID: 30629646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
